Works matching AU Habermann, Thomas

Results: 202
    1

    Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 980, doi. 10.1002/ajh.27663
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Perera, Nirosha D.;
    • Sarosiek, Shayna;
    • Gustine, Joshua;
    • Ramirez‐Gamero, Andres;
    • Varettoni, Marzia;
    • Tedeschi, Alessandra;
    • Cavalloni, Chiara;
    • Frustaci, Anna Maria;
    • Pederson, Levi D.;
    • Zanwar, Saurabh S.;
    • Kapoor, Prashant;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Geyer, Susan M.;
    • Treon, Steven P.;
    • Castillo, Jorge J.
    Publication type:
    Article
    2
    3
    4
    5
    6

    Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00711-8
    By:
    • Frechette, Kelsey M.;
    • Lester, Scott C.;
    • Taparra, Kekoa;
    • Breen, William G.;
    • Martenson, James A.;
    • Hoppe, Bradford S.;
    • Peterson, Jennifer L.;
    • Rule, William G.;
    • Stafford, Scott L.;
    • Stish, Bradley J.;
    • Habermann, Thomas M.;
    • Young, Jason R.;
    • Harmsen, William S.;
    • Laack, Nadia N.
    Publication type:
    Article
    7

    PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
    By:
    • Desai, Sanjal H.;
    • Pederson, Levi;
    • LaPlant, Betsy;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Young, Jason R.;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Cerhan, James R.;
    • Feldman, Andrew;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    8

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    9
    10

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    11

    Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
    By:
    • Arushi Khurana;
    • Mwangi, Raphael;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Strouse, Christopher;
    • Link, Brian K.;
    • Wang, Yucai;
    • King, Rebecca L.;
    • Macon, William R.;
    • Villasboas, J. C.;
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    12

    Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00521-4
    By:
    • Mondello, Patrizia;
    • Fama, Angelo;
    • Larson, Melissa C.;
    • Feldman, Andrew L.;
    • Villasboas, Jose C.;
    • Yang, Zhi-Zhang;
    • Galkin, Ilia;
    • Svelolkin, Viktor;
    • Postovalova, Ekaterina;
    • Bagaev, Alexander;
    • Ovcharov, Pavel;
    • Varlamova, Arina;
    • Huet, Sarah;
    • Tesson, Bruno;
    • McGrath, Kaitlyn R.;
    • Slager, Susan;
    • Link, Brian K.;
    • Syrbu, Sergei;
    • Novak, Anne J.;
    • Habermann, Thomas M.
    Publication type:
    Article
    13
    14

    Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
    By:
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Manske, Michelle K.;
    • Sarangi, Vivekananda;
    • Maurer, Matthew J.;
    • Larson, Melissa C.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • McPhail, Ellen;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • King, Rebecca L.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    15
    16

    Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
    By:
    • Wang, Yucai;
    • Wenzl, Kerstin;
    • Manske, Michelle K.;
    • Asmann, Yan W.;
    • Sarangi, Vivekananda;
    • Greipp, Patricia T.;
    • Krull, Jordan E.;
    • Hartert, Keenan;
    • He, Rong;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Slager, Susan L.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    17
    18
    19
    20

    Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.

    Published in:
    International Journal of Dermatology, 2002, v. 41, n. 6, p. 352, doi. 10.1111/j.1365-4632.2002.01501.x
    By:
    • Bouwhuis, Saskia A.;
    • el-Azhary, Rokea A.;
    • McEvoy, Marian T.;
    • Gibson, Lawrence E.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Pittelkow, Mark R.
    Publication type:
    Article
    21
    22

    Central nervous system involvement by mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
    By:
    • McLaughlin, Nicole;
    • Wang, Yucai;
    • Witzig, Thomas;
    • Villasboas, Jose;
    • Habermann, Thomas;
    • Inwards, David;
    • Bennani, Nora;
    • Thanarajasingam, Gita;
    • Nowakowski, Grzegorz;
    • Porrata, Luis;
    • Thompson, Carrie;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Paludo, Jonas
    Publication type:
    Article
    23
    24
    25

    Body mass index and survival of patients with lymphoma.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 11, p. 2671, doi. 10.1080/10428194.2021.1929956
    By:
    • Chihara, Dai;
    • Larson, Melissa C.;
    • Robinson, Dennis P.;
    • Thompson, Carrie A.;
    • Maurer, Matthew J.;
    • Casulo, Carla;
    • Pophali, Priyanka;
    • Link, Brian K.;
    • Habermann, Thomas M.;
    • Feldman, Andrew L.;
    • Flowers, Christopher R.;
    • Cerhan, James R.;
    • Morton, Lindsay M.
    Publication type:
    Article
    26

    Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 308, doi. 10.1080/10428194.2020.1832669
    By:
    • Gunaratne, Madugodaralalage D. S. K.;
    • Sahakian, Alexander J.;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant;
    • Paulus, Aneel;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Novak, Anne J.;
    • Lacy, Martha Q.;
    • Kyle, Robert A.;
    • Go, Ronald S.;
    • Paludo, Jonas
    Publication type:
    Article
    27

    The association of health behaviors with quality of life in lymphoma survivors.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 271, doi. 10.1080/10428194.2020.1830389
    By:
    • Pophali, Priyanka A.;
    • Larson, Melissa C.;
    • Rosenthal, Allison C.;
    • Robinson, Dennis;
    • Habermann, Thomas M.;
    • Thanarajasingam, Gita;
    • Call, Timothy;
    • Allmer, Cristine;
    • Farooq, Umar;
    • Maurer, Matthew J.;
    • Yost, Kathleen J.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    28

    Analysis and impact of a multidisciplinary lymphoma virtual tumor board.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 14, p. 3351, doi. 10.1080/10428194.2020.1817432
    By:
    • Habermann, Thomas M.;
    • Khurana, Arushi;
    • Lentz, Ruth;
    • Schmitz, John J.;
    • von Bormann, Alexander G.;
    • Young, Jason R.;
    • Hunt, Christopher H.;
    • Christofferson, Sara N.;
    • Nowakowski, Grzegorz S.;
    • McCullough, Kristen B.;
    • Horna, Pedro;
    • Wood, Adam J.;
    • Macon, William R.;
    • Kurtin, Paul J.;
    • Lester, Scott C.;
    • Stafford, Scott L.;
    • Chamarthy, Ushrasree;
    • Khan, Faraz;
    • Ansell, Stephen M.;
    • King, Rebecca L.
    Publication type:
    Article
    29

    Predictors of short-term survival in Waldenström Macroglobulinemia.

    Published in:
    2020
    By:
    • Ruan, Gordon;
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie;
    • Go, Ronald S.;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Paludo, Jonas;
    • Thanarajasingam, Gita;
    • Inwards, David J.;
    • Thompson, Carrie A.;
    • Habermann, Thomas M.;
    • Lin, Yi;
    • Nowakowski, Grzegorz S.;
    • Bisneto, Jose C. Villasboas;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Buadi, Francis K.;
    • Dingli, David
    Publication type:
    Letter
    30
    31
    32
    33
    34

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    35
    36
    37

    Relationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemiology Resource

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 8, p. 2365, doi. 10.3109/10428194.2014.994206
    By:
    • Wudhikarn, Kitsada;
    • Smith, Brian J.;
    • Button, Anna M.;
    • Habermann, Thomas M.;
    • Thompson, Carrie A.;
    • Rosenstein, Lori J.;
    • Syrbu, Sergei I.;
    • Weiner, George J.;
    • Cerhan, James R.;
    • Link, Brian K.
    Publication type:
    Article
    38

    Survival in patients with limited-stage peripheral T-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1665, doi. 10.3109/10428194.2014.963078
    By:
    • Briski, Robert;
    • Feldman, Andrew L.;
    • Bailey, Nathaniel G.;
    • Lim, Megan S.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Inwards, David J.;
    • Colgan, Joseph P.;
    • Nowakowski, Grzegorz S.;
    • Kaminski, Mark S.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    39
    40

    Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2728, doi. 10.3109/10428194.2014.893313
    By:
    • Porrata, Luis F.;
    • Ristow, Kay M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz;
    • Thompson, Carrie A.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    41
    42
    43

    Authors' Response.

    Published in:
    2006
    By:
    • Shanafelt, Tait;
    • West, Colin;
    • Kolars, Joseph;
    • Habermann, Thomas
    Publication type:
    Letter
    44
    45
    46

    CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1475, doi. 10.1007/s00262-013-1452-4
    By:
    • Charbonneau, Bridget;
    • Wang, Alice;
    • Maurer, Matthew;
    • Asmann, Yan;
    • Zent, Clive;
    • Link, Brian;
    • Ansell, Stephen;
    • Weiner, George;
    • Ozsan, Nazan;
    • Feldman, Andrew;
    • Witzig, Thomas;
    • Cunningham, Julie;
    • Dogan, Ahmet;
    • Habermann, Thomas;
    • Slager, Susan;
    • Novak, Anne;
    • Cerhan, James
    Publication type:
    Article
    47

    Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 606, doi. 10.1002/ajh.27630
    By:
    • Yamshon, Samuel;
    • Koff, Jean L.;
    • Larson, Melissa C.;
    • Kahl, Brad S.;
    • Casulo, Carla;
    • Lossos, Izidore S.;
    • Haddadi, Sara;
    • Stanchina, Michele;
    • Chihara, Dai;
    • Ayers, Amy;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Khurana, Arushi;
    • Nowakowski, Grzegorz S.;
    • Reicks, Tanner W.;
    • Farooq, Umar;
    • Link, Brian K.;
    • Cohen, Jonathon B.;
    • Martin, Peter;
    • Li, Jia
    Publication type:
    Article
    48
    49

    The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
    By:
    • Cerhan, James R.;
    • Maurer, Matthew J.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Habermann, Thomas M.;
    • Jaye, David L.;
    • Burack, W. Richard;
    • McDonnell, Timothy J.;
    • Vega, Francisco;
    • Chapman, Jennifer R.;
    • Syrbu, Sergei;
    • Vij, Kiran R.;
    • Inghirami, Giorgio;
    • Leonard, John P.;
    • Bernal‐Mizrachi, Leon;
    • Farooq, Umar;
    • Witzig, Thomas E.;
    • Weiner, George J.;
    • Wang, Yucai;
    • Alderuccio, Juan P.
    Publication type:
    Article
    50